Country: Spain
Language: English
Source: HMA (Heads of Medicines Agencies)
mycobacterium paratuberculosis inactivated 2.5 mg
CZ VETERINARIA
QI03AB01
Emulsion for injection
Mycobacterium
Goats Food, Sheep Food
2013-06-27
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT GUDAIR Emulsion for injection for sheep and goats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose (1ml) of the vaccine contains: ACTIVE SUBSTANCE: _Mycobacterium paratuberculosis_ inactivated, strain 316F ≥ 2 mm ITT avian PPD* *Increase of the skin thickness in the intradermal tuberculin test in sheep with avian protein derivative and in comparison with bovine protein derivative. ADJUVANT(S): Mineral oil (Marcol 52) 0.38 mL Montanide 103 0.021 mL Montane 80 0.021 mL EXCIPIENTS: Thiomersal 0.1 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Emulsion for injection 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Sheep and goats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _ _ Active immunisation of sheep and goats to reduce clinical signs, lesions and mortality caused by M. paratuberculosis. It also reduces _M. paratuberculosis_ faecal shedding in sheep. 4.3 CONTRAINDICATIONS None 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Vaccination sensitises animals against johnin PPD (Purified Protein Derivative of _Mycobacterium avium_ subsp. _paratuberculosis_), avian tuberculin PPD (derivative of _Mycobacterium avium_) and to lesser extend bovine tuberculin PPD (derivative of _Mycobacterium bovis_). The reaction against avian tuberculin PPD is more intense than against bovine tuberculin PPD and clearly distinguishable. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Use uninterruptedly once the extracti Read the complete document
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT GUDAIR Emulsion for injection for sheep and goats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose (1ml) of the vaccine contains: ACTIVE SUBSTANCE: _Mycobacterium paratuberculosis_ inactivated, strain 316F ≥ 2 mm ITT avian PPD* *Increase of the skin thickness in the intradermal tuberculin test in sheep with avian protein derivative and in comparison with bovine protein derivative. ADJUVANT(S): Mineral oil (Marcol 52) 0.38 mL Montanide 103 0.021 mL Montane 80 0.021 mL EXCIPIENTS: Thiomersal 0.1 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Emulsion for injection 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Sheep and goats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _ _ Active immunisation of sheep and goats to reduce clinical signs, lesions and mortality caused by M. paratuberculosis. It also reduces _M. paratuberculosis_ faecal shedding in sheep. 4.3 CONTRAINDICATIONS None 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Vaccination sensitises animals against johnin PPD (Purified Protein Derivative of _Mycobacterium avium_ subsp. _paratuberculosis_), avian tuberculin PPD (derivative of _Mycobacterium avium_) and to lesser extend bovine tuberculin PPD (derivative of _Mycobacterium bovis_). The reaction against avian tuberculin PPD is more intense than against bovine tuberculin PPD and clearly distinguishable. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Use uninterruptedly once the extracti Read the complete document